Sickle cell disease trials in India
4 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
- Where
- Bangalore, Gujarat, Maharashtra, Mumbai, New Delhi, Raipur
- Age
- 2 years and over
- People
- 480 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT06609226 · EU 2024-510805-27-00 - Phase 3Taking peopleA Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
- Where
- Bhubaneswar, Dohad, Guwahati, Hyderabad, Kozhikode, Mysuru, Nagpur, New Delhi, Noida, Raipur, Surat, Udaipur, Vadodara
- Age
- 12 years and over
- People
- 510 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT06612268 · EU 2023-509175-16-00 - Phase 2Taking peopleA Phase 2 Open-label Study to Evaluate the Activity of Etavopivat on Transcranial Doppler Velocities in Pediatric Patients With Sickle Cell Disease Who Are at Increased Risk for Primary Stroke
- Where
- Delhi, Gujarat, Maharashtra, Nagpur, Raipur
- Age
- 12 years to 16 years
- People
- 27 worldwide
- Run by
- Forma Therapeutics, Inc.
See details and how to joinNCT05953584 - Phase 2/3Taking peopleA Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
- Where
- Bhubaneswar, Nashik, New Delhi, Raipur, Surat, Vadodara
- Age
- 12 years to 64 years
- People
- 389 worldwide
- Run by
- Pfizer
See details and how to joinNCT05431088 · EU 2023-508766-14-00